Published on 16 Mar 2024 on Simply Wall St. via Yahoo Finance
There's been a notable change in appetite for Cryoport, Inc. (NASDAQ:CYRX) shares in the week since its yearly report, with the stock down 15% to US$14.73. It was a pretty bad result overall; while revenues were in line with expectations at US$233m, statutory losses exploded to US$2.21 per share. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Cryoport after the latest results.
See our latest analysis for Cryoport
earnings-and-revenue-growth